B-Cell CLL-Lymphoma 10 Protein
"B-Cell CLL-Lymphoma 10 Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A signal transducing adaptor protein that contains an N-terminal CARD DOMAIN and functions in the ADAPTIVE IMMUNE RESPONSE. It promotes PRO-CASPASE-9 maturation and APOPTOSIS, activation of NF-KAPPA B, and is a substrate for MALT1 PARACASPASE.
| Descriptor ID |
D000074018
|
| MeSH Number(s) |
D12.644.360.024.131.140 D12.644.360.075.358.140 D12.776.157.057.006.140 D12.776.476.024.139.140 D12.776.476.075.358.140
|
| Concept/Terms |
B-Cell CLL-Lymphoma 10 Protein- B-Cell CLL-Lymphoma 10 Protein
- B Cell CLL Lymphoma 10 Protein
- Bcl-10 Protein
- Bcl 10 Protein
- B-Cell Lymphoma-Leukemia 10 Protein
- B Cell Lymphoma Leukemia 10 Protein
- Bcl10 Protein
|
Below are MeSH descriptors whose meaning is more general than "B-Cell CLL-Lymphoma 10 Protein".
Below are MeSH descriptors whose meaning is more specific than "B-Cell CLL-Lymphoma 10 Protein".
This graph shows the total number of publications written about "B-Cell CLL-Lymphoma 10 Protein" by people in this website by year, and whether "B-Cell CLL-Lymphoma 10 Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "B-Cell CLL-Lymphoma 10 Protein" by people in Profiles.
-
Cellular metabolism constrains innate immune responses in early human ontogeny. Nat Commun. 2018 11 16; 9(1):4822.
-
Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase. Blood. 2014 Dec 11; 124(25):3758-67.
-
Carrageenan-induced colonic inflammation is reduced in Bcl10 null mice and increased in IL-10-deficient mice. Mediators Inflamm. 2013; 2013:397642.
-
From MALT lymphoma to the CBM signalosome: three decades of discovery. Cell Cycle. 2011 Aug 01; 10(15):2485-96.
-
CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells. J Immunol. 2009 Jun 01; 182(11):6736-43.
-
T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol Cell Biol. 2008 Apr; 28(7):2470-80.